AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Digital content for SillaJen, Inc

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
SillaJen, Inc
korearepublicofnew Flag
Country
Country
South Korea
Address
Address
F, 111, Hyoyeol-ro, Buk-gu, Busan, ZIP Code : 46508
Telephone
Telephone
+82(51) 517-7550
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/osr-holdings-and-sillajen-have-entered-into-a-memorandum-of-understanding-to-collaboratively-pursue-the-development-of-innovative-therapeutics-and-enter-the-us-market-302123230.html

PR NEWSWIRE
22 Apr 2024

https://www.businesswire.com/news/home/20240327409454/en

BUSINESSWIRE
27 Mar 2024

http://www.pharmabiz.com/NewsDetails.aspx?aid=153374&sid=2

PHARMABIZ
21 Sep 2022

https://www.globenewswire.com/news-release/2022/09/20/2518805/0/en/Basilea-announces-acquisition-of-rights-for-oncology-asset-BAL0891-by-SillaJen-and-updates-financial-guidance.html

GLOBENEWSWIRE
19 Sep 2022

https://www.theinvestor.co.kr/view.php?ud=20200512000831

THEINVESTOE
12 May 2020

https://endpts.com/after-disappointing-investors-sillajen-gets-into-trouble-with-korean-prosecutors-on-suspected-insider-trading/?utm_medium=email&utm_campaign=799%20Thursday%20August%2029%20-%20AbbVie%20officially%20kills%20its%20ailing%2010B%20Rova-T%20program%20AstraZeneca%20looks%20for%20a%20comeback%20win%20in%20lupus&utm_content=799%20Thursday%20August%2029%20-%20AbbVie%20officially%20kills%20its%20ailing%2010B%20Rova-T%20program%20AstraZeneca%20looks%20for%20a%20comeback%20win%20in%20lupus+CID_5676fd7dce51fa354d22b6e6bceff7fd&utm_source=ENDPOINTS%20emails&utm_term=After%20disappointing%20investors%20SillaJen%20gets%20into%20trouble%20with%20Korean%20prosecutors%20on%20suspected%20insider%20trading

Amber Tong ENDPTS
30 Aug 2019

https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-hifibio-s-kite-backed-c-round-kyowa-kirin-s-parkinson-s-nod-relief-for

Angus Liu FIERCE PHARMA
30 Aug 2019

https://endpts.com/bains-orly-mishan-joins-pfizers-neuro-spinout-cerevel-oncolytic-virus-biotech-taps-sillajen-exec-helena-chaye-as-ceo/?utm_medium=email&utm_campaign=790%20Friday%20August%2016%20-%206%20years%20after%20Sanofi%20killed%20it%20fedratinib%20wins%20FDA%20OK%20Top%2010%20franchise%20drugs%20in%20history%20offer%2014T%20lesson&utm_content=790%20Friday%20August%2016%20-%206%20years%20after%20Sanofi%20killed%20it%20fedratinib%20wins%20FDA%20OK%20Top%2010%20franchise%20drugs%20in%20history%20offer%2014T%20lesson+CID_0faf5d59b692c300e4ef716e0fddccee&utm_source=ENDPOINTS%20emails&utm_term=Peer%20Review%20Bains%20Orly%20Mishan%20joins%20Pfizers%20neuro%20spinout%20Cerevel%20Oncolytic%20virus%20biotech%20taps%20SillaJen%20exec%20Helena%20Chaye%20as%20CEO

John Carroll ENDPTS
17 Aug 2019

http://www.pharmafile.com/news/525968/transgene-terminates-oncolytic-io-combo-trial-advanced-liver-cancer

PHARMAFILE
08 Aug 2019

https://www.biospectrumasia.com/news/39/14156/sillajen-to-discontinue-phocus-trial-for-advanced-liver-cancer.html

BIOSPECTRUMASIA
05 Aug 2019
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY